DNAtrix, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| DNX-2440 for Resectable Colorectal Liver Metastasis (NCT04714983) | DNAtrix, Inc. | 2021-02-15 |
Track DNAtrix, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.